Mochi Health and Ro are two of the most visible names in online weight-loss care, and they take noticeably different approaches to pricing, care style, and medication. If you are choosing between them, here is a clear, current comparison.
Quick answer
Mochi Health uses a flat membership of about $79 a month covering visits and care coordination, with compounded GLP-1 medication options starting around $99 for semaglutide and $199 for tirzepatide, shipping included. Ro Body charges about $99 the first month and then $145 a month for membership, which does not include medication; you pay cash for the drug or use Ro's insurance concierge. Mochi leans on one-on-one video visits with providers and dietitians; Ro leans more on an asynchronous model. Neither accepts insurance for GLP-1 medications.
How pricing compares
| Item | Mochi Health | Ro Body |
|---|---|---|
| Membership | ~$79/month | ~$99 first month, then ~$145/month |
| Medication included? | Compounded GLP-1 bundled (from ~$99 semaglutide, ~$199 tirzepatide) | Not included; cash or insurance concierge |
| Shipping | Included | Varies |
| Insurance for GLP-1 meds | Not accepted | Not accepted (concierge helps seek coverage) |
The structural difference matters. Mochi bundles care and compounded medication into a relatively predictable monthly cost. Ro separates the membership fee from the medication, so your total depends heavily on what your prescribed drug costs and whether any insurance reimbursement comes through. For many cash-pay patients, separating those costs can push Ro's all-in total higher.
How the care models differ
Mochi Health emphasizes one-on-one video visits with licensed medical providers and registered dietitians, using shared decision-making across a range of GLP-1 options, including compounded choices when appropriate, and adjusting over time. The flat pricing and bundled medication suit people who want predictable costs and more hands-on coaching.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →Ro relies more heavily on an asynchronous model for intake and ongoing care, with video available but typically required only in certain states. Ro tends to position patients within its branded GLP-1 set, with coverage and supply influencing which drug is selected. This suits people comfortable with a more streamlined, message-based experience.
Medication approach
Mochi works across a wider range of GLP-1 options, including compounded semaglutide and tirzepatide, and emphasizes adjusting the plan with a provider. Ro focuses more on branded GLP-1 products, with availability and insurance shaping the choice. Neither platform accepts insurance for the GLP-1 medication itself, since most insurers treat these as weight-loss drugs rather than chronic-disease treatments. Both supply detailed invoices and letters of medical necessity that you can submit to your health plan for possible reimbursement.
Company background
Ro is the older company, founded in 2017, and has grown into a broad telehealth brand spanning multiple conditions. Mochi Health is a newer, weight-management-focused platform. Both publish medically reviewed articles and market themselves as clinician-led, but their scale and focus differ: Ro is a wide-spectrum telehealth player, while Mochi concentrates on metabolic and weight care.
Which one fits which patient
- Choose Mochi if you want predictable flat pricing, bundled compounded medication, and more one-on-one video coaching with providers and dietitians.
- Choose Ro if you prefer a streamlined, largely asynchronous experience, want help seeking insurance reimbursement, and are comfortable with a branded-medication focus.
Both are reasonable, clinician-led options, and the better fit comes down to how you want to pay and how much hands-on contact you want.
A third option to weigh
Mochi and Ro are not the only routes to compounded GLP-1 care. FormBlends connects patients with licensed providers and U.S. pharmacies for compounded semaglutide and tirzepatide with transparent monthly pricing and shipping. If you are comparing platforms on cost, medication options, and care model, our provider comparison tool lets you line up Mochi, Ro, and other programs side by side before you commit.
Frequently asked questions
Mochi vs Ro, which is cheaper? Mochi's bundled model is often more predictable; Ro separates membership from medication, which can raise the total. Compare your specific prescribed medication cost.
Does Mochi or Ro take insurance for GLP-1 meds? Neither accepts insurance for the medication. Both provide invoices and letters of medical necessity for possible reimbursement.
What does Mochi Health cost? About $79 a month for membership, with compounded GLP-1 medication from roughly $99 (semaglutide) or $199 (tirzepatide), shipping included.
What does Ro Body cost? About $99 the first month, then $145 a month for membership, not including medication.
Which has more personal care? Mochi emphasizes one-on-one video visits with providers and dietitians; Ro leans more asynchronous.
What are alternatives to Mochi and Ro? Other telehealth GLP-1 programs and platforms like FormBlends that connect patients with licensed providers and compounded medication.
Is Mochi or Ro better for tirzepatide? Mochi offers compounded tirzepatide in its bundled pricing; Ro's tirzepatide access depends on its branded set and supply. Compare current offerings.
When was each company founded? Ro was founded in 2017; Mochi Health is a newer, weight-focused platform.
Sources
- Mochi Health. Mochi Health vs Ro: weight loss programs compared. https://joinmochi.com/blogs/mochi-health-vs-ro-weight-loss-programs-compared
- Explore Providers. Mochi vs Ro: compare GLP-1 programs and pricing. https://www.exploreproviders.com/mochi-vs-ro/
- U.S. News Health. Mochi Health GLP-1 medications for weight loss review. https://health.usnews.com/best-diet/medication/mochi-health
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →